NCT06938555

Brief Summary

The investigators are interested in finding out how Prolonged Nightly Fasting (PNF) and/or health education may impact health and cancer recovery for breast cancer patients and survivors.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
8mo left

Started Mar 2025

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress64%
Mar 2025Dec 2026

Study Start

First participant enrolled

March 18, 2025

Completed
10 days until next milestone

First Submitted

Initial submission to the registry

March 28, 2025

Completed
25 days until next milestone

First Posted

Study publicly available on registry

April 22, 2025

Completed
1.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2026

Last Updated

May 1, 2026

Status Verified

April 1, 2026

Enrollment Period

1.8 years

First QC Date

March 28, 2025

Last Update Submit

April 27, 2026

Conditions

Keywords

breast cancerbreast cancer survivorbrain fogprolonged nightly fastingnationwideremotenon-invasivehealth educationsleepquality of life

Outcome Measures

Primary Outcomes (2)

  • Examine PNF-induced changes in cognitive function as compared to the HED-Only control condition.

    The Functional Assessment of Cancer Therapy-Cognitive Function (FACT-Cog) will be used to assess subjective cognitive function using a scale of 0-156

    Baseline (T1) and 8-week end point (T2) data collection

  • Examine PNF-induced changes in cognitive function as compared to the HED-Only control condition.

    The Montreal Cognitive Assessment (T-MoCA) will be used to assess objective cognitive assessment using a scale of 0-22

    Baseline (T1) and 8-week end point (T2) data collection

Secondary Outcomes (3)

  • Examine PNF-induced changes in sleep (i.e., duration, quality) and insomnia as compared to the HED-Only Control condition.

    Baseline (T1) and 8-week end point (T2) data collection

  • Examine PNF-induced changes in sleep (i.e., duration, quality) and insomnia as compared to the HED-Only Control condition.

    Baseline (T1) and 8-week end point (T2) data collection

  • Examine PNF-induced changes in quality of life as compared to the HED-Only Control condition.

    Baseline (T1) and 8-week end point (T2) data collection.

Other Outcomes (4)

  • Exploratory Aim: Explore acceptability of the PNF intervention

    8-week end point (T2) data collection

  • Exploratory Aim: Explore acceptability of the PNF intervention

    8-week end point (T2) data collection

  • Exploratory Aim: Explore acceptability of the PNF intervention

    8-week end point (T2) data collection

  • +1 more other outcomes

Study Arms (2)

Prolonged Nightly Fasting and Health Education Videos

EXPERIMENTAL

Participants in the Prolonge + HED condition will receive both the Prolonged Nightly Fasting and the Health Education Video interventions.

Behavioral: Prolonged Nightly FastingBehavioral: Health Education Videos

Health Education Videos Only

ACTIVE COMPARATOR

Participants in the Health Education Only condition will participate in only the Health Education Video intervention. Investigators will provide materials about Prolonged Nightly Fasting to these participants at the end of the study.

Behavioral: Health Education Videos

Interventions

At the start of the intervention (week 1) PNF participants will be asked to engage in fasting (14 hours a night, starting no later than 8pm) six nights a week (for the 8-week study duration). Participants will be asked to track their fasting start/stop times on a tracking sheet provided by study staff. During the nightly fast, participants will be allowed to drink water, coffee or tea (without dairy or sweeteners). Study staff will meet with participants via phone for weekly check-in calls (\~10-15 mins) to collect weekly fasting start/stop dates/times (entered into REDCap); alternately, participants may elect to email or text their fasting start/stop date/times to the study staff.

Prolonged Nightly Fasting and Health Education Videos

Provision of HED is a retention strategy and can influence outcomes. Thus, all participants will receive HED. Each week, participants will receive hyperlinks to videos focused on health educational content unrelated to fasting, diet and outcome measures. Participants will be asked to view the videos (\~10-15 min) prior to their weekly check-in calls with the study staff (\~5-10 mins for HED-Only Control group). They will receive each week's videos on a Monday, and receive a reminder to view on Friday. Study staff will follow a scripted HED weekly check-in call to ensure consistency of data collected. Weekly topics are as follows: W1: Internet safety, W2: Sun safety, W3: Home safety, W4: Driving safety, W5: Hydration, W6: Dental health, W7: Working environment, W8: Communication. Data collected on electronic forms during all participant/staff check-in calls will be stored in participant-specific ASU Dropbox files.

Health Education Videos OnlyProlonged Nightly Fasting and Health Education Videos

Eligibility Criteria

Age18 Years+
Sexall(Gender-based eligibility)
Gender Eligibility DetailsParticipants must identify as women
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • ≥18 years old
  • diagnosed with breast cancer (all stages included)
  • ≥3 months post neoadjuvant or adjuvant chemotherapy (maintenance or palliative systemic therapy is included)
  • score ≤30 or lower on the Patient Reported Outcome Measurement Information System Cognitive Function Short Form 8a (sr-CRCI)
  • able to speak/understand English
  • have access to a computer and Wi-Fi
  • live within the United States
  • Identifies as female
  • willing and able to fully participate in the study

You may not qualify if:

  • type 1 diabetes
  • actively enrolled in formal diet/weight loss program
  • previous bariatric surgery
  • eating disorder history
  • night shift work
  • pregnant, breast feeding, or trying to get pregnant
  • dementia, psychological, psychiatric, or neurological diagnoses
  • active brain or central nervous system disease
  • prior or current use of memory enhancing medications
  • history or current brain radiation
  • frequently fasting for 12+ hours every night
  • \) history of hypoglycemia 14) depression screening on PHQ9 with a score of 20 or greater across all 9 questions OR anything other than 0 on question 9

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Arizona State University

Phoenix, Arizona, 85004, United States

RECRUITING

MeSH Terms

Conditions

Breast NeoplasmsMental FatigueHealth Education

Condition Hierarchy (Ancestors)

Neoplasms by SiteNeoplasmsBreast DiseasesSkin DiseasesSkin and Connective Tissue DiseasesFatigueSigns and SymptomsPathological Conditions, Signs and SymptomsBehavioral SymptomsBehaviorAdherence InterventionsMedication AdherencePatient CompliancePatient Acceptance of Health CareTreatment Adherence and ComplianceHealth Behavior

Study Officials

  • Dorothy Sears, PhD

    Arizona State University

    PRINCIPAL INVESTIGATOR
  • Sarah James, MD, PhD

    Mayo Clinic

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Jen Project Coordinator

CONTACT

Dorothy Sears, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
INVESTIGATOR
Masking Details
Statistician will also be masked to condition
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: One group will be assigned to Prolonged Nightly Fasting (PNF) and Health Education videos, the other group will be assigned to Health Education videos.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Executive Director and Professor

Study Record Dates

First Submitted

March 28, 2025

First Posted

April 22, 2025

Study Start

March 18, 2025

Primary Completion (Estimated)

December 31, 2026

Study Completion (Estimated)

December 31, 2026

Last Updated

May 1, 2026

Record last verified: 2026-04

Data Sharing

IPD Sharing
Will not share

Protocol and consent state, "De-identified data collected as a part of this study will not be shared with other investigators or industry partners for future research purposes." This is a pilot study and only aggregated data may be shared.

Locations